|
Volumn 17, Issue 3-4, 2009, Pages 78-79
|
Pharmacoeconomic analysis of antineoplastics at the Oncology Institute of Vojvodina from 2005 to 2008
|
Author keywords
Drug delivery systems; Economics, pharmaceutical; Medical oncology
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAPECITABINE;
CETUXIMAB;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
IRINOTECAN;
MONOCLONAL ANTIBODY;
OXALIPLATIN;
PACLITAXEL;
RITUXIMAB;
TRASTUZUMAB;
CANCER CELL;
COST OF ILLNESS;
DRUG COST;
DRUG SELECTIVITY;
IMMUNE RESPONSE;
MEDICAL SOCIETY;
REVIEW;
SERBIA;
TUMOR IMMUNITY;
|
EID: 76749107560
PISSN: 03547310
EISSN: 14509520
Source Type: Journal
DOI: 10.2298/AOO0904078I Document Type: Review |
Times cited : (2)
|
References (6)
|